Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.

Pinzón-Ramírez V, Cueva-Cañola LE, Natera DE, Olivera HEA, Camacho-Hernández OE, Beltran-De la Fuente AC, Ramirez-Alvarez SA, Cubas EYG, Flores GV, Gamez ME, Castilla LR

Open source

DOI: 10.3332/ecancer.2026.2115
Published: 2026
Container: Ecancermedicalscience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3332/ecancer.2026.2115,
  title = {Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.},
  author = {Pinzón-Ramírez V and Cueva-Cañola LE and Natera DE and Olivera HEA and Camacho-Hernández OE and Beltran-De la Fuente AC and Ramirez-Alvarez SA and Cubas EYG and Flores GV and Gamez ME and Castilla LR},
  year = {2026},
  journal = {Ecancermedicalscience},
  doi = {10.3332/ecancer.2026.2115},
  url = {https://doi.org/10.3332/ecancer.2026.2115}
}

RIS

TY  - JOUR
TI  - Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.
AU  - Pinzón-Ramírez V
AU  - Cueva-Cañola LE
AU  - Natera DE
AU  - Olivera HEA
AU  - Camacho-Hernández OE
AU  - Beltran-De la Fuente AC
AU  - Ramirez-Alvarez SA
AU  - Cubas EYG
AU  - Flores GV
AU  - Gamez ME
AU  - Castilla LR
PY  - 2026
JO  - Ecancermedicalscience
DO  - 10.3332/ecancer.2026.2115
UR  - https://doi.org/10.3332/ecancer.2026.2115
ER  -

APA

V, P., LE, C., DE, N., HEA, O., OE, C., AC, B. L. F., SA, R., EYG, C., GV, F., ME, G., & LR, C. (2026). Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2026.2115

Source records

pubmed · retrieved 2026-09-25T21:37:03.961Z